| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > News and Society > Death: The Great Equalizer |
|
Top Adding - Death: The Great Equalizer
The recent deaths of Dana Reeve and Kirby Puckett in their mid-forties once again show us just how short life really is According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product and how we must deal with that fact. Both were successful people who should have had many more years of life. However, d ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ath comes when it comes and there truly is no set time. Of course, the shock seeing these two people die makes us look lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t our own lives. How long do I have? That is a common question and totally appropriate. People often pretend they have " here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe orever" when in reality a person is very lucky to have eighty years. With all of the advancements of medicine and variou d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s surgeries, the average age for men is about seventy-five and for women about eighty. That's it. We are not going to li ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e for two hundred years. America plays down death except for sensationalism purposes. However, it is a good thing to ex easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lore death in one's mind because it is going to happen. Anyone over the age of thirty-five should slowly start making pl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ns-certainly mentally- for the inevitable. Dying is an incredible thing in another way: It truly makes us all equal. Yo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ u could be a billionaire or not have a thing. Both are going in the same direction. It does not discriminate in terms of ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi race or gender; it comes the way of all. There is nothing funnier (in a cynical way)than seeing old people filled with ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a go and pride. One would figure by that point common sense would kick in. Again, money is no shield in the way of foolish dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ess. Billionaire Donald Trump is a perfect example of this. He recently ripped Martha Stewart to pieces in a letter sent cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to the press for her performance in "The Apprentice." It was one of those "I-am-great-and-you-suck" type of letters. Ba tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ically, his version of the show does well and hers, well, tanked. So, in response to a minor comment by Stewart, Trump w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nt nuts and ripped her from A to Z. Give it a break Donald! You are going to be sixty years old in a couple of months. R ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust pping on the senior citizen Stewart was pretty cruel. Perhaps going nuts gives him vitality in his mind and takes focus y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products off of his death. The thought of death is certainly a scary thing. But it is very common, almost too common. We are mea . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t to die. Coming to terms with that fact makes for a more sane life instead of denial and game playing. The end will com elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip for every living thing and for this writer, dealing with it and asking God for strength are the only ways to look at it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:List Building - How Do I Generate a Vast Number of Subscribers to My List? An Introduction to Google Sitemaps How To Save More Money On Your New Car Loan
|